Lin Guo Ren - Net Worth and Insider Trading

Lin Guo Ren Net Worth

The estimated net worth of Lin Guo Ren is at least $1 Million dollars as of 2024-06-22. Lin Guo Ren is the senior management of Harbin Pharmaceutical Group Co Ltd and owns about 500,000 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) stock worth over $1 Million. Details can be seen in Lin Guo Ren's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lin Guo Ren has not made any transactions after 2022-04-14 and currently still holds the listed stock(s).

Transaction Summary of Lin Guo Ren

To

Lin Guo Ren Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lin Guo Ren owns 1 companies in total, including Harbin Pharmaceutical Group Co Ltd (SHSE:600664) .

Click here to see the complete history of Lin Guo Ren’s form 4 insider trades.

Insider Ownership Summary of Lin Guo Ren

Ticker Comapny Transaction Date Type of Owner
SHSE:600664 Harbin Pharmaceutical Group Co Ltd 2022-04-14 senior management

Lin Guo Ren Latest Holdings Summary

Lin Guo Ren currently owns a total of 1 stock. Lin Guo Ren owns 500,000 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) as of April 14, 2022, with a value of $1 Million.

Latest Holdings of Lin Guo Ren

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600664 Harbin Pharmaceutical Group Co Ltd 2022-04-14 500,000 2.73 1,365,000

Holding Weightings of Lin Guo Ren


Lin Guo Ren Form 4 Trading Tracker

According to the SEC Form 4 filings, Lin Guo Ren has made a total of 1 transactions in Harbin Pharmaceutical Group Co Ltd (SHSE:600664) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Harbin Pharmaceutical Group Co Ltd is the sale of 500,000 shares on April 14, 2022, which brought Lin Guo Ren around $805,000.

Insider Trading History of Lin Guo Ren

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lin Guo Ren Trading Performance

GuruFocus tracks the stock performance after each of Lin Guo Ren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lin Guo Ren is -6.54%. GuruFocus also compares Lin Guo Ren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lin Guo Ren within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lin Guo Ren's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lin Guo Ren

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.48 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.91 LIMIT LIMIT LIMIT LIMIT LIMIT

Lin Guo Ren Ownership Network

Ownership Network List of Lin Guo Ren

No Data

Ownership Network Relation of Lin Guo Ren

Insider Network Chart

Lin Guo Ren Owned Company Details

What does Harbin Pharmaceutical Group Co Ltd do?

Who are the key executives at Harbin Pharmaceutical Group Co Ltd?

Lin Guo Ren is the senior management of Harbin Pharmaceutical Group Co Ltd. Other key executives at Harbin Pharmaceutical Group Co Ltd include senior management Wang Hai Sheng , senior management Liu Bo , and senior management Meng Xiao Dong .

Harbin Pharmaceutical Group Co Ltd (SHSE:600664) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harbin Pharmaceutical Group Co Ltd (SHSE:600664) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Harbin Pharmaceutical Group Co Ltd (SHSE:600664)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harbin Pharmaceutical Group Co Ltd Insider Transactions

No Available Data

Lin Guo Ren Mailing Address

Above is the net worth, insider trading, and ownership report for Lin Guo Ren. Currently GuruFocus does not have mailing address information for Lin Guo Ren.

Discussions on Lin Guo Ren

No discussions yet.